Status:
UNKNOWN
Impact of AI on Trainee ADR
Lead Sponsor:
University of Southern California
Conditions:
Adenoma
Adenoma Colon
Eligibility:
All Genders
Phase:
NA
Brief Summary
Adenoma detection rate (ADR) is a validated quality metric for colonoscopy with higher ADR correlated with improved colorectal cancer outcomes. Artificial intelligence (AI) can automatically detect po...
Detailed Description
Our objective is to determine the impact of AI on the adenoma detection rate of Gastroenterology trainees. The secondary aim of this quality improvement study is to determine the impact of AI based en...
Eligibility Criteria
Inclusion
- All Gastroenterology fellows at USC performing Endoscopies will be included in the study.
Exclusion
- If fellows refuse informed consent they will be excluded.
- Procedures performed in the intensive care unit or the operating room will not be counted toward the study metrics as the AI system will only be available in the endoscopy unit.
- If procedures are performed only by faculty, in which the fellow is not the primary operator, they will not be used for study metrics.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05423964
Start Date
January 1 2023
End Date
September 1 2025
Last Update
March 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LAC+USC Medical Center
Los Angeles, California, United States, 90033